Executive Summary
This digest covers a single HHS contract record totaling $91,580,433 in obligations, all civilian and none defense-related. The dominant theme is continued NIH/NIAID funding for infectious disease research infrastructure, awarded to American Type Culture Collection (Manassas, VA). The highest-conviction read is the cost-plus-fixed-fee structure, which shifts cost-overrun risk to the government and implies lower margin volatility.
The primary watch item is option exercise: the $91,580,433 obligated represents only a fraction of the $334,258,869 base-plus-options value, so most potential value depends on future option decisions. The recipient is a nonprofit with no public-equity data in the source, so direct stock-level investment read-through is limited; the signal is best treated as a durable research-services award rather than an equity catalyst.
Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →
Tracking the trend? Catch up on the prior HHS & Healthcare Contracts Intelligence digest from October 09, 2026.
Investment Signals (1)
- American Type Culture Collection BEI-RRP award: $91,580,433 obligated against $334,258,869 potential value (MEDIUM)▲
The NIH/NIAID cost-plus-fixed-fee contract has $57,345,176 outlayed to date, indicating active execution against the obligated amount. Value beyond the current obligation depends on option exercises that are not guaranteed.
Risk Flags (1)
- Budget [MEDIUM RISK]▼
Roughly 73% of the $334,258,869 base-plus-options value is not yet obligated; realization of the full value depends on NIH/NIAID exercising future options and on continued appropriations for the BEI-RRP program.
Opportunities (1)
- ◆
Continued NIH/NIAID research-services demand for biological resources and emerging infections work positions American Type Culture Collection for follow-on or expanded task orders if options are exercised.
Sector Themes (1)
- ◆
NIH/NIAID's $91,580,433 obligation under a cost-plus-fixed-fee award (NAICS 541715, PSC AN12) indicates continued federal investment in biological resources and infectious disease research infrastructure. The data does not establish multi-year budget direction beyond this award.
Watch List (1)
- 👁
{"entity" => "American Type Culture Collection / NIH-NIAID BEI-RRP program", "reason" => "$91,580,433 obligated of $334,258,869 potential value, with $57,345,176 outlayed; full value depends on option exercises.", "trigger" => "Option exercise decisions and any modification to the 2027-10-15 current end date ahead of the 2031-04-14 potential end date"}
Get daily alerts with 1 investment signals, 1 risk alerts, 1 opportunities and full AI analysis of all 1 filings
$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.
More from: HHS & Healthcare Contracts Intelligence
October 01, 2026
HHS & Healthcare Contracts Intelligence — October 01, 2026
September 11, 2026
HHS & Healthcare Contracts Intelligence — September 11, 2026
September 10, 2026
HHS & Healthcare Contracts Intelligence — September 10, 2026
September 03, 2026
HHS & Healthcare Contracts Intelligence — September 03, 2026
🇺🇸 More from United States
View all →October 10, 2026
VA Healthcare & Services Contracts — October 10, 2026
VA Healthcare & Services Contracts
October 10, 2026
DHS Homeland Security Contracts — October 10, 2026
DHS Homeland Security Contracts
October 10, 2026
Federal Professional Services Contracts — October 10, 2026
Federal Professional Services Contracts
October 10, 2026
Contract Option Exercises — October 10, 2026
Contract Option Exercises